Gene Addition Strategies for β-Thalassemia and Sickle Cell Anemia.

Abstract excerpt

Beta-thalassemia and sickle cell anemia are two of the most common diseases related to the hemoglobin protein. In these diseases, the beta-globin gene is mutated, causing severe anemia and ineffective erythropoiesis. Patients can additionally present with a number of life-threatening co-morbidities, such as stroke or spontaneous fractures. Current treatment involves transfusion and iron chelation; allogeneic bone...

Topics

Join the communities discussing this publication.

• Anemia, Sickle Cell
• beta-Globins
• beta-Thalassemia
• Bone Marrow Transplantation
• Genetic Therapy